In Vivo Reprogramming of hTERT by Trans-splicing Ribozyme to Target Tumor Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In Vivo Reprogramming of hTERT by Trans-splicing Ribozyme to Target Tumor Cells

Published:2008-01 Issue:1 Volume:16 Page:74-80
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Hong Seung-Hee,Jeong Jin-Sook,Lee Yoon-Jong,Jung Haeng-Im,Cho Kyoung-Sook,Kim Chang-Min,Kwon Byung-Su,Sullenger Bruce A,Lee Seong-Wook,Kim In-Hoo

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference36 articles.

1. Cancer gene therapy: fringe or cutting edge?;McCormick;Nat Rev Cancer,2001

2. Transcriptionally targeted gene therapy to detect and treat cancer;Wu;Trends Mol Med,2003

3. Targeted gene therapy: frontiers in the development of ‘smart drugs’;Tarner;Trends Biotechnol,2004

4. One binding site determines sequence specificity of Tetrahymena pre-rRNA self-splicing, trans-splicing, and RNA enzyme activity;Been;Cell,1986

5. Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing;Sullenger;Nature,1994

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA splicing based on reporter genes system: Detection, imaging and applications;Coordination Chemistry Reviews;2023-02

2. Non-Canonical Splicing and Its Implications in Brain Physiology and Cancer;International Journal of Molecular Sciences;2022-03-04

3. Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells;Nature Biotechnology;2022-03-03

4. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors;Pharmaceuticals;2021-06-10

5. Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation;Molecular Therapy - Nucleic Acids;2021-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3